Application no. and date | 08847113.1 (espacenet) (Federated) (European Patent Register), 20081107 | Patent/reg. no. and date | DK/EP 2205244, 20130821 | Publication date | 20100714 | Priority no. and date | US 2583 P, 20071108, US 5803 P, 20071207, US 98676 P, 20080919, US 112060 P, 20081106 | EP pub. no. and date |
EP 2205244 20100714 | Effective date | | Applicant/owner | Ambit Biosciences Corporation,
11080 Roselle Street San Diego, CA 92121, US | Applicant ref. no. | P81313843DK00E | Inventor | JAMES, Joyce, K., 1931 Chalcedony Street
San Diego CA 92109, US, EICHELBERGER, Shawn R., 4215 Sorrento Valley Blvd.
San Diego, CA 92121, US, SAVALL, Traci L., 4215 Sorrento Valley Blvd.
San Diego, CA 92121, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/5377 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) | Title | FREMGANGSMÅDER TIL INDGIVELSE AF N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N'-{4-[7-(2-MORPHOLIN-4-YL-ETHOXY-)IMIDAZO-[2,1-B]-[1,3]-BENZOTHIAZOL-2-YL]-PHENYL}URINSTOF TIL BEHANDLING AF PROLIFERATIV SYGDOM | Int. application no. | US2008012539 | Int. publication no. | WO2009061446 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|